Literature DB >> 3772504

Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.

J M Feldman, R A Blinder, K J Lucas, R E Coleman.   

Abstract

Iodine-131 metaiodobenzylguanidine ([131I]MIBG) is concentrated in pheochromocytomas and can be detected by external imaging. We administered [131I]MIBG to 23 patients with carcinoid tumors to determine if it would be useful in scanning patients with these tumors. The carcinoid tumors of 14 of the 23 patients (61%) were visualized. Iodine-131 MIBG was concentrated most avidly by tumors of midgut origin (ileum, cecum); it was concentrated less avidly by some tumors of foregut origin (pancreas, stomach); it was not significantly concentrated by other tumors of foregut origin (bronchus). We conclude that 131I is a useful imaging agent for carcinoid tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772504

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Detecting pheochromocytoma: defining the most sensitive test.

Authors:  Ulrich Guller; Joe Turek; Steve Eubanks; Elizabeth R Delong; Daniel Oertli; Jerome M Feldman
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 2.  Tubulovillous adenoma of the duodenum: a new etiology for flushing and urinary 5-HIAA elevation.

Authors:  S A Betchen; M Cirigliano; E E Furth; D Broussard; M Grippi; G R Lichtenstein
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

Review 3.  Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.

Authors:  C Mao; A el Attar; D R Domenico; K Kim; J M Howard
Journal:  Int J Pancreatol       Date:  1998-04

4.  The role of I-131-MIBG in the diagnosis and therapy of carcinoids.

Authors:  C A Hoefnagel; F C den Hartog Jager; B G Taal; N G Abeling; E E Engelsman
Journal:  Eur J Nucl Med       Date:  1987

5.  Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Authors:  D Macfarlane; J Gonin; D Wieland; T Mangner; J Froelich; W Beierwaltes; B Shapiro
Journal:  Eur J Nucl Med       Date:  1996-02

6.  131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?

Authors:  A Osei-Bonsu; E M Kokoschka; W Ulrich; H Sinzinger
Journal:  Eur J Nucl Med       Date:  1989

Review 7.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

8.  Somatostatin analogue scintigraphy in carcinoid tumours.

Authors:  D J Kwekkeboom; E P Krenning; W H Bakker; H Y Oei; P P Kooij; S W Lamberts
Journal:  Eur J Nucl Med       Date:  1993-04

9.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

10.  Avid thallium-201 uptake in hepatic carcinoid metastases.

Authors:  R Nour; R J Quinn; D L Morris; S P Butler
Journal:  Eur J Nucl Med       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.